Open AccessChemoprevention of gastric cancer development afterHelicobacter pylorieradication therapy in an East Asian population: Meta-analysis
Author(s) -
Mitsushige Sugimoto,
Masaki Murata,
Yoshio Yamaoka
Publication year - 2020
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v26.i15.1820
Subject(s) - medicine , helicobacter pylori , atrophic gastritis , gastroenterology , incidence (geometry) , population , cancer , cohort , randomized controlled trial , cochrane library , cohort study , meta analysis , gastritis , environmental health , optics , physics
Helicobacter pylori ( H. pylori ) infection is a risk factor for gastric cancer (GC), especially in East Asian populations. Most East Asian populations infected with H. pylori are at higher risk for GC than H. pylori -positive European and United States populations. H. pylori eradication therapy reduces gastric cancer risk in patients after endoscopic and operative resection for GC, as well as in non-GC patients with atrophic gastritis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom